These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3321071)

  • 1. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.
    Rio MC; Bellocq JP; Gairard B; Rasmussen UB; Krust A; Koehl C; Calderoli H; Schiff V; Renaud R; Chambon P
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9243-7. PubMed ID: 3321071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers.
    Delvenne CG; Winkler-Gol RA; Piccart MJ; Hustin J; Michaux D; Leclercq G; Nogaret JM; Autier P
    Eur J Cancer; 1992; 28(2-3):700-5. PubMed ID: 1350458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells.
    Stack G; Kumar V; Green S; Ponglikitmongkol M; Berry M; Rio MC; Nunez AM; Roberts M; Koehl C; Bellocq P
    Cancer Treat Res; 1988; 40():185-206. PubMed ID: 2908650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.
    Cho HS; NG PA; Katzenellenbogen BS
    Mol Endocrinol; 1991 Sep; 5(9):1323-30. PubMed ID: 1722871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors.
    Saegusa M; Hashimura M; Hara A; Okayasu I
    J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer.
    Zaretsky JZ; Weiss M; Tsarfaty I; Hareuveni M; Wreschner DH; Keydar I
    FEBS Lett; 1990 Jun; 265(1-2):46-50. PubMed ID: 2194831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
    Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
    Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
    Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
    Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
    Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
    Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
    Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
    Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
    Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific expression of human pS2 gene in breast cancer].
    Rio MC; Bellocq JP; Gairard B; Koehl C; Renaud R; Chambon P
    Biochimie; 1988 Jul; 70(7):961-8. PubMed ID: 3145028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between mammaglobin expression and estrogen receptor status in breast tumors.
    Guan XF; Hamedani MK; Adeyinka A; Walker C; Kemp A; Murphy LC; Watson PH; Leygue E
    Endocrine; 2003 Aug; 21(3):245-50. PubMed ID: 14515009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines.
    Tong D; Czerwenka K; Sedlak J; Schneeberger C; Schiebel I; Concin N; Leodolter S; Zeillinger R
    Breast Cancer Res Treat; 1999 Jul; 56(1):91-7. PubMed ID: 10517346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma.
    Kardaś I; Seitz G; Limon J; Niezabitowski A; Ryś J; Theisinger B; Welter C; Blin N
    Cancer; 1993 Sep; 72(5):1652-6. PubMed ID: 8394203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of pS2 mRNA in breast cancer.
    Wysocki SJ; Iacopetta BJ; Ingram DM
    Eur J Cancer; 1994; 30A(12):1882-4. PubMed ID: 7880621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.